To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 336 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 0.7% of the total position.
      1.41KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 27,594 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.91% of the total position.
      2.86KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 13,314 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.27% of the total position.
      1.38KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 371 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 1.1% of the total position.
      734Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 217 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.89% of the total position.
      675Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Incyte by 1,134 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.06% of the total position.
      234Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,715 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.7% of the total position.
      169Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 41,692 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.56% of the total position.
      187Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 17,969 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.92% of the total position.
      203Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 93,387 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.79% of the total position.
      4.46KComment
      Report
       
       
       
       

      Most Discussed